James E. O’Brien
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Epidemiology top 10%
- Congenital Heart Disease Studies
Papers in
- Epidemiology 21
- Congenital Heart Disease Studies 18
-
- Congenital heart defects research 8
- RNA modifications and cancer 6
- RNA Research and Splicing 4
- Co-authors
- Jennifer Marshall (15 shared papers)Douglas C. Bittel (14 shared papers)Nataliya Kibiryeva (12 shared papers)Gary K. Lofland (9 shared papers)Jie Chen (2 shared papers)O. N. Hinsvark (4 shared papers)Calvin Hanna (1 shared paper)Michael Artman (2 shared papers)
- Journals
- The Annals of Thoracic Surgery (10 papers)PLoS ONE (2 papers)Journal of Pediatric Surgery (2 papers)Journal of Thoracic and Cardiovascular Surgery (2 papers)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
James E. O’Brien
52 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 111
- Cancer Research 146
- Epidemiology 312
- Surgery 212
- Molecular Biology 337
- Pulmonary and Respiratory Medicine 119
Countries citing papers authored by James E. O’Brien
This map shows the geographic impact of James E. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. O’Brien more than expected).
Fields of papers citing papers by James E. O’Brien
This network shows the impact of papers produced by James E. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. O’Brien. The network helps show where James E. O’Brien may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. O’Brien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 110 | |
| 2 | 2011 | 95 | |
| 3 | 1997 | 51 | |
| 4 | 2014 | 48 | |
| 5 | 2012 | 44 | |
| 6 | 2008 | 44 | |
| 7 | 2001 | 42 | |
| 8 | 1963 | 39 | |
| 9 | 2019 | 36 | |
| 10 | 1998 | 34 | |
| 11 | 2020 | 28 | |
| 12 | 2016 | 28 | |
| 13 | 1979 | 28 | |
| 14 | 1972 | 27 | |
| 15 | 2018 | 26 | |
| 16 | 2015 | 25 | |
| 17 | 2018 | 22 | |
| 18 | 2023 | 21 | |
| 19 | 2012 | 21 | |
| 20 | 2010 | 21 |
About James E. O’Brien
James E. O’Brien is a scholar working on Epidemiology, Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Congenital Heart Disease Studies (18 papers), Congenital heart defects research (8 papers), RNA modifications and cancer (6 papers), RNA Research and Splicing (4 papers), Congenital Diaphragmatic Hernia Studies (4 papers), Cancer-related molecular mechanisms research (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Pharmacological Effects and Assays (2 papers). The work is most often cited by research in Cancer Research (146 citations), Epidemiology (312 citations), Surgery (212 citations), Molecular Biology (337 citations) and Pulmonary and Respiratory Medicine (119 citations). James E. O’Brien has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jennifer Marshall, Douglas C. Bittel, Nataliya Kibiryeva, Gary K. Lofland, Jie Chen, O. N. Hinsvark, Calvin Hanna, Michael Artman, Merlin G. Butler and John D. Mannion. Their work appears in journals such as The Annals of Thoracic Surgery, PLoS ONE, Journal of Pediatric Surgery, Journal of Thoracic and Cardiovascular Surgery and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.